|
IPHAF
|
It’s about time for Atrium to reveal trial results. This could be the next...
|
|
IPHAF
|
|
|
IPHAF
|
It’s possible these smart guys and gals will figure out...
|
|
IPHAF
|
Maybe in February we will get some info.
|
|
IPHAF
|
It will be nice to have a clear picture on this company, one way or the other...
|
|
IPHAF
|
Lux banks $50M as it readies new drug launch Lux Biosciences announced this...
|
|
IPHAF
|
Biostock01 AS you are aware,This is from another board;Those ranking...
|
|
IPHAF
|
I forgot to mention I am positive on the company.
|
|
IPHAF
|
naomi2,For the most part this is posturing, similar to Isotechnika’s recent...
|
|
IPHAF
|
It’s probably share price appreciation from here until the announcement, then...
|
|
IPHAF
|
Good article thanks, after reading it I started to wonder if Paladin is...
|
|
IPHAF
|
To give Isotechnika some legs, share price wise, we need someone to...
|
|
IPHAF
|
I think he’s in some sort of denial.
|
|
IPHAF
|
Plato5 ,Since we are playing the guessing game, I believe your reading too...
|
|
IPHAF
|
Great…news about a product that could be 15 years from the prospect of being...
|
|
IPHAF
|
WASKERWISK,I believe you’re over confident and not informed enough to make...
|
|
IPHAF
|
It’s a wonderful thing to be enlightened.Single-blind...
|
|
IPHAF
|
This first trial for CE approval has been ongoing since June 2008, and is not...
|
|
IPHAF
|
I wonder why it’s taking Atrium so long to chirp in.
|
|
IPHAF
|
The criteria for institutional investors are not being met (see link). I don...
|